Description
Tadarise oral jelly (Tadalafil) 20 mg
Tadarise oral jelly 20 mg is a tadalafil-containing oral jelly product. Tadalafil is a phosphodiesterase type 5 (PDE5) inhibitor used for erectile dysfunction in approved tadalafil products. This description is based on verified information for tadalafil; the Tadarise oral jelly brand itself could not be confirmed from official regulatory sources.
Active Ingredient and Medicine Class
The verified active ingredient is tadalafil, which belongs to the PDE5 inhibitor class. Tadalafil is available in multiple authorised oral formulations in regulated markets, including tablet and oral suspension products.
Established Medical Uses
In official prescribing information, tadalafil is indicated for the treatment of erectile dysfunction. Some authorised products are also indicated for other conditions such as benign prostatic hyperplasia or pulmonary arterial hypertension, depending on the product and jurisdiction. The product described here is presented for erectile dysfunction use only because that is the only use supported by the supplied product description and the evidence reviewed.
How It Works
Tadalafil helps relax smooth muscle and increase blood flow in the penis by inhibiting PDE5, an enzyme that breaks down cyclic guanosine monophosphate (cGMP). This supports the normal erectile response to sexual stimulation. Tadalafil has a long duration of action compared with some other PDE5 inhibitors, with clinical studies showing responsiveness out to 36 hours after dosing.
Important Safety Information
Tadalafil is contraindicated with organic nitrates because the combination can cause a dangerous fall in blood pressure. Prescribing information also warns about clinically important interactions with alpha-blockers and other blood-pressure-lowering medicines. It should not be used with other PDE5 inhibitors or erectile dysfunction therapies. Caution is also needed in people with significant cardiovascular disease, because sexual activity itself may carry risk in some patients.
Serious but uncommon safety concerns described in official labeling include priapism, sudden decrease or loss of vision, and sudden decrease or loss of hearing.
Possible Side Effects
Commonly reported adverse effects include headache, dyspepsia, back pain, myalgia, flushing, and nasal congestion. Clinical trials and reviews also describe dizziness and limb pain in some patients. Most events in studies were mild to moderate.
Scientific Evidence
Randomized placebo-controlled trials found that tadalafil 20 mg improved erectile function, intercourse success, and patient-reported satisfaction in men with erectile dysfunction. A separate trial showed benefit at both 24 and 36 hours after dosing, supporting tadalafil’s longer treatment window. Reviews and meta-analyses also support its overall efficacy and tolerability in erectile dysfunction.
Medical Information Notice
This page is an educational summary based on sources available at the time of review. It does not replace the official patient leaflet, prescribing information, or assessment by a qualified healthcare professional.
Medical Sources
- U.S. FDA / DailyMed: Tadalafil Tablets, Full Prescribing Information
- FDA: CIALIS (tadalafil) tablets, Highlights of Prescribing Information
- Porst H. et al. “Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: a randomized controlled trial.” Urology (2003). PubMed
